Cargando…
Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis
Arthritis is a chronic disease with a significant impact on the population. It damages the cartilage, synovium, and bone of the joints causing pain, impairment, and disability in patients. Current methods for diagnosis of and monitoring the disease are only able to detect clinical manifestations of...
Autores principales: | Tseng, Susan, Reddi, A. Hari, Di Cesare, Paul E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716683/ https://www.ncbi.nlm.nih.gov/pubmed/19652761 |
Ejemplares similares
-
Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity
por: Saghafi, Massoud, et al.
Publicado: (2017) -
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003) -
Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions
por: Bond, Andrew R., et al.
Publicado: (2014) -
COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis
por: Sandstedt, Joakim, et al.
Publicado: (2021) -
Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
por: Rydell, Emil, et al.
Publicado: (2023)